EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tryptophan and Its Selected Metabolites Modulate Melanoma-Cell Biology: A Preliminary In Vitro Study

Anna Michalak-Stoma iD, Katarzyna Walczak, Małgorzata Kowal, Katarzyna Sawa-Wejksza, Michał Chojnacki iD, Marta Kinga Lemieszek iD, Filip Stoma iD, Dorota Krasowska iD

International Journal of Molecular Sciences · 05.11.2026 · 27 (21) · 9908

DOI: 10.3390/ijms27219908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.11.2026. Verfasst von Anna Michalak-Stoma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Dermatology, Venereology and Paediatric Dermatology, Medical University of Lublin, Staszica 11, 20-081 Lublin, Poland. Hauptthemen laut MEDLINE: Tryptophan, Melanoma. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, Medical University of Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tryptophan (TRP) and its metabolites are involved in numerous physiological and pathological processes within the skin. They may influence melanoma biology, but their role remains insufficiently understood. This study investigated the effects of TRP, anthranilic acid (AA), and cinnabarinic acid (CBA) in melanoma cells in vitro and their potential interaction with the B-Raf proto-oncogene, serine/threonine kinase (BRAF) inhibitor vemurafenib. A375, G361, and SK-MEL-3 melanoma cell lines and a THP-1-derived macrophage model were used. Cell proliferation and metabolic activity were assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, migration using a scratch assay, and cell-cycle distribution by flow cytometry. Western blotting was used to analyze selected signaling proteins. Reactive oxygen species (ROS) and nitric oxide (NO) production were evaluated. Bioinformatic analyses investigated associations between BRAF and genes related to tryptophan metabolism and the kynurenine pathway. All compounds showed dose-dependent antiproliferative effects, with prolonged exposure increasing efficacy. TRP and AA increased G0/G1 cell-cycle arrest, whereas CBA increased the G2/M population. TRP also reduced A375 cell migration. All three compounds enhanced the antiproliferative effect of vemurafenib, with CBA showing the strongest effect (approximately 20%). Western blot analysis indicated modulation of p21 expression and ERK1/2 phosphorylation, suggesting implications for cell cycle and stress signaling pathways. Moreover, conditioned medium from A375 cells exposed to tested compounds affected cell viability, ROS, and NO production in THP-1-derived macrophages. TRP and its metabolites may be considered potential supportive agents for melanoma BRAF-targeted therapy. However, further in vivo studies are needed to clarify their therapeutic value and to elucidate the underlying molecular mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TryptophanMelanomaHumansVemurafenibProto-Oncogene MasCell ProliferationCell Line, TumorReactive Oxygen SpeciesCell MovementProto-Oncogene Proteins B-rafortho-AminobenzoatesNitric Oxide

Stichwörter der Autor:innen

BRAFanthranilic acidcell cyclecinnabarinic acidkynurenine pathwaymelanomatryptophantryptophan metabolismtumor–immune interactionsvemurafenib

Substanzen

TryptophanVemurafenibProto-Oncogene MasMAS1 protein, humanReactive Oxygen SpeciesProto-Oncogene Proteins B-rafortho-Aminobenzoatesanthranilic acidNitric OxideBRAF protein, human

Autor:innen und Institutionen

  • Chair and Department of Dermatology, Venereology and Paediatric Dermatology, Medical University of Lublin, Staszica 11, 20-081 Lublin, Poland.
  • Laboratory for Immunology of Skin Diseases, Chair and Department of Dermatology, Venereology and Paediatric Dermatology, Medical University of Lublin, Radziwiłłowska 11, 20-080 Lublin, Poland.
  • Department of Virology and Immunology, Maria Curie-Sklodowska University, Akademicka 19, 20-033 Lublin, Poland.
  • Department of Medical Biology, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland.
  • Chair and Department of Neurosurgery, Medical University of Lublin, Jaczewskiego 8, 20-090 Lublin, Poland.

ORCID-Profile: Anna Michalak-Stoma, Michał Chojnacki, Marta Kinga Lemieszek, Filip Stoma, Dorota Krasowska

Förderung

  • National Science Centre
  • Medical University of Lublin

Zitieren

APA

Michalak-Stoma, A., Walczak, K., Kowal, M., Sawa-Wejksza, K., Chojnacki, M., Lemieszek, M. K., Stoma, F., & Krasowska, D. (2026). Tryptophan and Its Selected Metabolites Modulate Melanoma-Cell Biology: A Preliminary In Vitro Study. International Journal of Molecular Sciences, 27(21), 9908. https://doi.org/10.3390/ijms27219908

Vancouver

Michalak-Stoma A, Walczak K, Kowal M, Sawa-Wejksza K, Chojnacki M, Lemieszek MK, et al. Tryptophan and Its Selected Metabolites Modulate Melanoma-Cell Biology: A Preliminary In Vitro Study. International Journal of Molecular Sciences. 2026;27(21):9908. doi:10.3390/ijms27219908

BibTeX
@article{MichalakStoma2026,
  author = {Michalak-Stoma, Anna and Walczak, Katarzyna and Kowal, Małgorzata and Sawa-Wejksza, Katarzyna and Chojnacki, Michał and Lemieszek, Marta Kinga and Stoma, Filip and Krasowska, Dorota},
  title = {Tryptophan and Its Selected Metabolites Modulate Melanoma-Cell Biology: A Preliminary In Vitro Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9908},
  doi = {10.3390/ijms27219908}
}
Kostenlos starten →